Carbamic acid, N-[[[2-[[4-[4-(3-bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]amino]sulfonyl]-, 9H-fluoren-9-ylmethyl ester
|
|
Carbamic acid, N-[[[2-[[4-[4-(3-bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]amino]sulfonyl]-, 9H-fluoren-9-ylmethyl ester Eigenschaften
- Dichte
- 1.78±0.1 g/cm3(Predicted)
- pka
- 4.04±0.40(Predicted)
Sicherheit
Carbamic acid, N-[[[2-[[4-[4-(3-bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]amino]sulfonyl]-, 9H-fluoren-9-ylmethyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden
Carbamic acid, N-[[[2-[[4-[4-(3-bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]amino]sulfonyl]-, 9H-fluoren-9-ylmethyl ester Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Carbamic acid, N-[[[2-[[4-[4-(3-bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]amino]sulfonyl]-, 9H-fluoren-9-ylmethyl ester Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 7)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 |
sales@molcore.com | China | 49734 | 58 |
Shanghai Jizhi Biochemical Technology Co. Ltd. | 4009004166/18616739031 18616739031 |
3007523370@qq.com | China | 52693 | 58 |
Taizhou Nanfeng Pharmaceutical Research Institute | 18616377689 |
nanfengdrug@163.com | China | 20565 | 58 |
Shanghai Haohong Pharmaceutical Co., Ltd. | 4008210725 4008210725 |
malulu@leyan.com | China | 54986 | 58 |
TCI (Shanghai) Chemical Trading Co., Ltd. | 021-021-61109150 |
sales@tcisct.com | China | 31121 | 58 |
Jiangsu Qianyu Molecular Technology Co., Ltd | 18136353590 |
2314725130@qq.com | China | 1054 | 58 |
https://hanhongsci.com/ | 021-54306202 18917919676 |
info@hanhongsci.com | China | 29977 | 58 |
- Carbamic acid, N-[[[2-[[4-[4-(3-bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]amino]sulfonyl]-, 9H-fluoren-9-ylmethyl ester
- (9H-fluoren-9-yl)methyl N-(2-((4-(4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,2,5-oxadiazol-3-yl)amino)ethyl)sulfamoylcarbamate
- 1771804-78-4
- C27H21BrFN7O7S